Cargando…
A comprehensive framework identifying barriers to global health R&D innovation and access
Advancements in research and development (R&D) have the potential to address pressing global health challenges. However, numerous barriers hinder innovation and access, particularly in areas of market failure, and there is an absence of a cohesive consensus on defining these various impediments....
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533694/ https://www.ncbi.nlm.nih.gov/pubmed/37751936 http://dx.doi.org/10.1136/bmjgh-2023-013076 |
_version_ | 1785112236781469696 |
---|---|
author | Ong, Ming |
author_facet | Ong, Ming |
author_sort | Ong, Ming |
collection | PubMed |
description | Advancements in research and development (R&D) have the potential to address pressing global health challenges. However, numerous barriers hinder innovation and access, particularly in areas of market failure, and there is an absence of a cohesive consensus on defining these various impediments. This paper presents a framework identifying the barriers that impede global health innovation and hinder equitable access to health technologies. The framework presents clear typologies of barriers across global health R&D thematic areas. These include the market failures that require R&D incentives to stimulate innovation, how the complexity of product registration hinders access within specific regulatory domains and how health system implementation issues prevent affected populations from accessing the tools they require. Current and historical examples are provided for each end-point, and three case studies explore key barriers and how solutions have or may be applied. This analysis contributes by adding to the body of knowledge on global health R&D and provides an analysis tool to policy-makers, researchers and stakeholders involved in addressing the barriers and promoting equitable access to healthcare innovations. The framework serves as a practical tool to guide future research, policy development and implementation efforts towards achieving sustainable global health outcomes. |
format | Online Article Text |
id | pubmed-10533694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-105336942023-09-29 A comprehensive framework identifying barriers to global health R&D innovation and access Ong, Ming BMJ Glob Health Analysis Advancements in research and development (R&D) have the potential to address pressing global health challenges. However, numerous barriers hinder innovation and access, particularly in areas of market failure, and there is an absence of a cohesive consensus on defining these various impediments. This paper presents a framework identifying the barriers that impede global health innovation and hinder equitable access to health technologies. The framework presents clear typologies of barriers across global health R&D thematic areas. These include the market failures that require R&D incentives to stimulate innovation, how the complexity of product registration hinders access within specific regulatory domains and how health system implementation issues prevent affected populations from accessing the tools they require. Current and historical examples are provided for each end-point, and three case studies explore key barriers and how solutions have or may be applied. This analysis contributes by adding to the body of knowledge on global health R&D and provides an analysis tool to policy-makers, researchers and stakeholders involved in addressing the barriers and promoting equitable access to healthcare innovations. The framework serves as a practical tool to guide future research, policy development and implementation efforts towards achieving sustainable global health outcomes. BMJ Publishing Group 2023-09-26 /pmc/articles/PMC10533694/ /pubmed/37751936 http://dx.doi.org/10.1136/bmjgh-2023-013076 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Analysis Ong, Ming A comprehensive framework identifying barriers to global health R&D innovation and access |
title | A comprehensive framework identifying barriers to global health R&D innovation and access |
title_full | A comprehensive framework identifying barriers to global health R&D innovation and access |
title_fullStr | A comprehensive framework identifying barriers to global health R&D innovation and access |
title_full_unstemmed | A comprehensive framework identifying barriers to global health R&D innovation and access |
title_short | A comprehensive framework identifying barriers to global health R&D innovation and access |
title_sort | comprehensive framework identifying barriers to global health r&d innovation and access |
topic | Analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533694/ https://www.ncbi.nlm.nih.gov/pubmed/37751936 http://dx.doi.org/10.1136/bmjgh-2023-013076 |
work_keys_str_mv | AT ongming acomprehensiveframeworkidentifyingbarrierstoglobalhealthrdinnovationandaccess AT ongming comprehensiveframeworkidentifyingbarrierstoglobalhealthrdinnovationandaccess |